Literature DB >> 15869947

Effect of intrastriatal 6-OHDA lesion on dopaminergic innervation of the rat cortex and globus pallidus.

Thomas Debeir1, Laure Ginestet, Chantal François, Stéphanie Laurens, Jean-Claude Martel, Philippe Chopin, Marc Marien, Francis Colpaert, Rita Raisman-Vozari.   

Abstract

The present study examined in the rat the effect of a partial lesion of the nigrostriatal dopaminergic pathway induced by intrastriatal injection of 6-hydroxydopamine (6-OHDA), on the dopaminergic innervation of the cortex and the globus pallidus as revealed using tyrosine hydroxylase (TH) immunoreactivity. Twenty-eight days after unilateral injection of 6-OHDA into the dorsal part of the striatum, TH-positive fiber density was reduced by 41% in the dorsal and central part of the structure, and was accompanied by a retrograde loss of 33% of TH-positive neurons in the substantia nigra (SN), while the ventral tegmental area was completely spared. In the SN, TH-positive cell loss was most severe in the ventral part of the structure (-55%). In the same animals, a substantial loss of TH-positive fibers was evident in the dorsal part of the globus pallidus, and involved both thick fibers of passage and thin varicose terminal axonal branches. In the cortex, a loss of TH-positive fibers was prominent in the cingulate area, moderate in the motor area and less affected in the insular area, while the noradrenergic innervation revealed using dopamine-beta-hydroxylase immunoreactivity was preserved in all of these cortical subregions. These results demonstrate that the intrastriatal 6-OHDA lesion model in rats produces a significant loss of dopaminergic axons in extrastriatal structures including the pallidum and cortex, which may contribute to functional sequelae in this animal model of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15869947     DOI: 10.1016/j.expneurol.2005.01.007

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  29 in total

Review 1.  The external globus pallidus: progress and perspectives.

Authors:  Daniel J Hegeman; Ellie S Hong; Vivian M Hernández; C Savio Chan
Journal:  Eur J Neurosci       Date:  2016-03-28       Impact factor: 3.386

Review 2.  Critical involvement of the motor cortex in the pathophysiology and treatment of Parkinson's disease.

Authors:  David Lindenbach; Christopher Bishop
Journal:  Neurosci Biobehav Rev       Date:  2013-10-07       Impact factor: 8.989

3.  Altered Recruitment of Motor Cortex Neuronal Activity During the Grasping Phase of Skilled Reaching in a Chronic Rat Model of Unilateral Parkinsonism.

Authors:  Brian I Hyland; Sonja Seeger-Armbruster; Roseanna A Smither; Louise C Parr-Brownlie
Journal:  J Neurosci       Date:  2019-10-22       Impact factor: 6.167

4.  Inhibition of DAT function attenuates manganese accumulation in the globus pallidus.

Authors:  Joel G Anderson; Paula T Cooney; Keith M Erikson
Journal:  Environ Toxicol Pharmacol       Date:  2007-03       Impact factor: 4.860

5.  The therapeutic effects of tyrosine hydroxylase gene transfected hematopoetic stem cells in a rat model of Parkinson's disease.

Authors:  Shizhong Zhang; Zhihao Zou; Xiaodan Jiang; Ruxiang Xu; Wangming Zhang; Yuan Zhou; Yiquan Ke
Journal:  Cell Mol Neurobiol       Date:  2007-08-23       Impact factor: 5.046

6.  Intrastriatal 6-OHDA lesion differentially affects dopaminergic neurons in the ventral tegmental area of prenatally stressed rats.

Authors:  Carlos J Baier; María Eugenia Pallarés; Ezequiela Adrover; María R Katunar; Rita Raisman-Vozari; Marta C Antonelli
Journal:  Neurotox Res       Date:  2014-06-17       Impact factor: 3.911

7.  Roles of dopaminergic innervation of nucleus accumbens shell and dorsolateral caudate-putamen in cue-induced morphine seeking after prolonged abstinence and the underlying D1- and D2-like receptor mechanisms in rats.

Authors:  Jun Gao; Yonghui Li; Ning Zhu; Stephen Brimijoin; Nan Sui
Journal:  J Psychopharmacol       Date:  2012-11-13       Impact factor: 4.153

8.  Alterations in primary motor cortex neurotransmission and gene expression in hemi-parkinsonian rats with drug-induced dyskinesia.

Authors:  D Lindenbach; M M Conti; C Y Ostock; K B Dupre; C Bishop
Journal:  Neuroscience       Date:  2015-09-09       Impact factor: 3.590

9.  Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons.

Authors:  Maria Sundberg; Helle Bogetofte; Tristan Lawson; Johan Jansson; Gaynor Smith; Arnar Astradsson; Michele Moore; Teresia Osborn; Oliver Cooper; Roger Spealman; Penelope Hallett; Ole Isacson
Journal:  Stem Cells       Date:  2013-08       Impact factor: 6.277

10.  Non-invasive evaluation of nigrostriatal neuropathology in a proteasome inhibitor rodent model of Parkinson's disease.

Authors:  Anthony C Vernon; Saga M Johansson; Michel M Modo
Journal:  BMC Neurosci       Date:  2010-01-05       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.